Literature DB >> 26193444

Lanthanide(III) complexes are more active inhibitors of the Fenton reaction than pure ligands.

Jan Martin1, Přemysl Mladěnka2, Luciano Saso3, Irena Kostova4.   

Abstract

OBJECTIVES: This study is an extension to our finding of direct anti-oxidant activities of lanthanide(III) complexes with the heterocyclic compound, 5-aminoorotic acid (AOA). In this experiment, we used AOA and coumarin-3-carboxylic acid as the two heterocyclic compounds with anti-oxidant potential, to produce the complexes with different lanthanides.
METHODS: Lanthanide(III) complexes were tested on the iron-driven Fenton reaction. The product of this reaction, the hydroxyl radical, was detected by HPLC.
RESULTS: All complexes as well as their ligands had positive or neutral effect on the Fenton reaction but their behavior was different. Both pure ligands in low concentration ratio to iron were inefficient in contrast to some of their complexes. Complexes of neodymium, samarium, gadolinium, and partly of cerium blocked the Fenton reaction at very low ratios (in relation to iron) but the effect disappeared at higher ratios. In contrast, lanthanum complexes appeared to be the most promising. Both blocked the Fenton reaction in a dose-dependent manner.
CONCLUSION: Lanthanide(III) complexes were proven to block the iron-driven production of the hydroxyl radical. Second, the lanthanide(III) element appears to be crucial for the anti-oxidant effect. Overall, lanthanum complexes may be promising direct anti-oxidants for future testing.

Entities:  

Keywords:  5-Aminoorotic acid; Anti-oxidant; Coumarin-3-carboxylic acid; Iron; Lanthanide(III)

Mesh:

Substances:

Year:  2016        PMID: 26193444      PMCID: PMC6837644          DOI: 10.1179/1351000215Y.0000000031

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  15 in total

1.  New lanthanide complexes with antioxidant activity.

Authors:  Irena Kostova; Maria Traykova; Vinod K Rastogi
Journal:  Med Chem       Date:  2008-07       Impact factor: 2.745

Review 2.  Synthetic and natural coumarins as cytotoxic agents.

Authors:  Irena Kostova
Journal:  Curr Med Chem Anticancer Agents       Date:  2005-01

3.  Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA.

Authors:  M J Laughton; B Halliwell; P J Evans; J R Hoult
Journal:  Biochem Pharmacol       Date:  1989-09-01       Impact factor: 5.858

4.  Synthesis and antihyperlipidemic activity of novel coumarin bisindole derivatives.

Authors:  Koneni V Sashidhara; Abdhesh Kumar; Manoj Kumar; Anuj Srivastava; Anju Puri
Journal:  Bioorg Med Chem Lett       Date:  2010-09-16       Impact factor: 2.823

Review 5.  Coumarins as inhibitors of HIV reverse transcriptase.

Authors:  Irena Kostova
Journal:  Curr HIV Res       Date:  2006-07       Impact factor: 1.581

6.  Synthesis, characterization and cytotoxic/cytostatic activity of La(III) and Dy(III) complexes.

Authors:  Irena Kostova; Tsvetanka Stefanova
Journal:  J Trace Elem Med Biol       Date:  2009-08-08       Impact factor: 3.849

7.  Theoretical, spectral characterization and antineoplastic activity of new lanthanide complexes.

Authors:  Irena Kostova; Natasha Trendafilova; Georgi Momekov
Journal:  J Trace Elem Med Biol       Date:  2008-03-04       Impact factor: 3.849

8.  Iron reduction potentiates hydroxyl radical formation only in flavonols.

Authors:  Kateřina Macáková; Přemysl Mladěnka; Tomáš Filipský; Michal Říha; Luděk Jahodář; František Trejtnar; Paolo Bovicelli; Ilaria Proietti Silvestri; Radomír Hrdina; Luciano Saso
Journal:  Food Chem       Date:  2012-07-14       Impact factor: 7.514

9.  Hydroxyl radical formation via iron-mediated Fenton chemistry is inhibited by methylated catechols.

Authors:  A J Nappi; E Vass
Journal:  Biochim Biophys Acta       Date:  1998-09-16

10.  New Samarium(III), Gadolinium(III), and Dysprosium(III) Complexes of Coumarin-3-Carboxylic Acid as Antiproliferative Agents.

Authors:  Irena Kostova; Georgi Momekov; Peya Stancheva
Journal:  Met Based Drugs       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.